Genexine Counting On Hyleukin-7’s Potential As Versatile I-O Booster
Sees Future In Cell-Related Therapies
Genexine’s recent M&A activity and foreign partnerships underscore its strategy on pipeline innovative therapeutics and biobetters as well as preparations to secure future growth engines, the Korean firm's vice-president tells Scrip in an interview.
